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Abstract
Our previous study showed anti-influenza virus activity in adlay tea prepared from adlay seeds, naked barley seeds, soybean, and
cassia seeds. In this study, we evaluated the anti-influenza virus activity of each component of this tea and analyzed their active
ingredients. Each component was roasted and extracted in hot water; the extracts were tested for antiviral activity and their
mechanisms of action were studied. All the tea components showed antiviral activity against the H1N1 and H3N2 influenza
subtypes and against influenza B. The viral stages inhibited by the components were virus adsorption and replication in
proliferative process, suggesting that the action mechanisms of the components might differ from those of oseltamivir acid. Of
the tea components, soybean showed the strongest activity. Therefore, we analyzed its active ingredients by liquid chromatog-
raphy quadruple time-of-flight mass spectrometry (LC/qTOF-MS) and daidzein and glycitein were detected as active ingredients.
Here, anti-influenza virus action of glycitein was the first report.
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Abbreviations
IFV Influenza virus
CDC Centers for Disease Control and Prevention
MDCK Madin–Darby canine kidney
FBS Fetal bovine serum
EMEM Eagle’s minimum essential medium
DMEM Dulbecco’s modified Eagle’s medium
BSA Bovine serum albumin
MOI Multiplicity of infection
FFRA Focus-forming reduction assay
SD Standard deviation
IC50 Half maximal inhibitory concentration
CC50 50% cytotoxicity concentration
SIM Selected ion monitoring
Introduction
The influenza virus (IFV) is an RNA virus belonging to the
family Orthomyxoviridae. There are three types in humans,
influenza A, B, and C, with types A and B being particularly
prevalent each winter. Infection with the virus can sometimes
result in severe complications such as pneumonia and enceph-
alitis [1]. Vaccines and antiviral drugs are used for the preven-
tion and treatment of infection, respectively; however, the
U.S. Centers for Disease Control and Prevention (CDC) has
reported the adjusted vaccine effectiveness estimates for the
influenza seasons from 2004 to 2019 to be 10 to 60% [2],
indicating that the vaccines cannot reveal a stable preventive
effect. In addition, the emergence of IFV strains resistant to
amantadine and neuraminidase has become a serious problem
in recent years [3–5]. Thus, a novel approach to protect against
IFV infection is required.
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Recently, functional food ingredients have received in-
creased attention, with many reports of anti-IFV activity by
various food ingredients, including tea polyphenols such as
catechins, theaflavins, and procyanidins [6]. There have also
been studies of the neuraminidase inhibitory activities of cat-
echins in green tea [7–9], and of their inhibitory effect on IFV
growth through acidification of the intercellular compartment
[10, 11]. Besides, green tea has an inhibitory effect on nuclear
factor-kappa B (NF-κB) which is a critical regulator of genes
involved in inflammation, cell proliferation, and apoptosis
[12]. It has also been suggested that cocoa polyphenols and
anthocyanin pigments in hibiscus tea show anti-IFV activity
[13, 14].
Our previous study [15] showed that adlay tea prepared
from adlay seeds, naked barley seeds, soybean, and cassia
seeds exhibited strong anti-IFV activity against the H1N1
and H3N2 subtypes and influenza B through inhibiting virus
replication and virus adsorption to cells. The anti-IFVactivity
of the tea was effective even against oseltamivir-resistant vi-
ruses, suggesting that the mechanism of action of the tea dif-
fered from that of oseltamivir, a drug that inhibits viral neur-
aminidase [3]. In the present study, we conducted a detailed
research of the anti-IFV activity of each component of the
adlay tea, identifying the active ingredients.
Materials and Methods
Compounds
Daidzein, glycitein, biochanin A, and genistein were pur-
chased from Wako Pure Chemical Industries, Ltd., Osaka,
Japan.
Hot Water Extracts of the Four Adlay Tea Components
Adlay seeds (Coix lacryma-jobi L. var. ma-yuen;
Akishizuku brand), naked barley seeds (Hordeum vulgare
var. nudum; Ichibanboshi brand), soybeans (Glycine max;
Sachiyutaka brand), and cassia seeds (Cassia obtusifolia
L.) were provided by Sanyo, Co., Ltd., Kobe, Japan.
These were roasted at 180 °C for 4 h and then powdered.
Some of the roasted powder (2 g) was mixed with water
(50 ml) and extracted in a hot water bath for 60 min at
80 °C, as described previously [15]. The extract was filtered
through No. 2 filter paper followed by a Millex GV mem-
brane (24 mm diameter and 0.22 μm pore size; Millipore,
Billerica, MA) and freeze-dried. Each lyophilizate was fur-
ther dissolved in same amount of water as that used before
freeze-drying, filtered through a Millex GX membrane, and
stored at −30 °C until further use.
Cells and Viruses
Madin–Darby canine kidney (MDCK) cells were cultured in
Eagle’s minimum essential medium (MEM; Sigma-Aldrich,
Inc., St. Louis, MO) containing 7% fetal bovine serum (FBS).
CV-1 cells were cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM; Sigma-Aldrich) containing 10% FBS. The
following IFVs were used: influenza A H1N1 virus strains
Puerto Rico/8/34 (PR/8/34), New Caledonia/20/99, and
Beijing/262/95; oseltamivir-resistant influenza A H1N1 virus
strains Osaka/2024/2009 and Osaka/71/2011 (provided by
Osaka Prefectural Institute of Public Health); influenza A
H3N2 virus strains Aichi/2/68 and Sydney/5/97); and influen-
za B virus strains Nagasaki/1/87 and Shanghai/261/2002.
These were propagated in MDCK cells and cultured in
DMEM containing 0.4% bovine serum albumin (BSA) and
2 μg/ml of acetyl trypsin (Sigma-Aldrich).
Antiviral Assays of the Hot Water Extracts
An antiviral assay was performed following the method of
Kamei et al. [14] with slight modifications. IFV solution at a
multiplicity of infection (MOI) of 0.0001 was added to
MDCK cells in a 24-well plate (Thermo Fisher Scientific
Inc., MA) and incubated for 1 h at 37 °C in 5% CO2. The
cells were washed with serum-free MEM and cultured in
DMEM containing 0.4% BSA and 2 μg/ml acetyl trypsin plus
hot water extract for 24–48 h at 37 °C in 5% CO2. Virus titers
were assessed in the culture supernatants by focus-forming
reduction assay (FFRA), as described previously [15]. The
anti-influenza effect was evaluated by determining the
Selectivity index = CC50/IC50 (IC50, half maximal inhibitory
concentration; CC50, 50% cytotoxicity concentration).
Time-of-Addition Assay
A time-of-addition assay was performed following the method
of Furuta et al. [16] with slight modifications.
Cytotoxic Testing and Hemagglutination Inhibition
and Cell Fusion Inhibition Assays
Cytotoxic testing of the hot water extracts was performed by
using a Cell proliferation kit (Roche Diagnostics Co. Ltd.,
Basel, Switzerland) following the manufacturer’s protocol.
Hemagglutination inhibition assays were performed by using
a standard microassay [17]. The cell fusion inhibition assays
followed the method of our previous study [15]. The influenza
virus solution (PR/8/34: MOI of 0.001) was infected into CV-
1 cells and cultured for 24 h. The infected cells were washed
twice and incubated for 15min in DMEM containing 10μl/ml
trypsin. The cells were washed twice and incubated for 30min
in DMEM plus hot water extract. The cells were washed and
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treated with fusion medium to adjust to pH 5.0 and incubated
for 2 min. The cells were washed twice and incubated for 3 h
with DMEM containing 2% FBS. The cells were stained with
Giemsa and the number of fused cells were counted.
Purification and Identification of Antiviral
Compounds in the Hot Water Extract of Soybean
Roasted powder from the soybeans (2 g) was mixed with
water (50 ml), and extracted in hot water bath at 80 °C for
60 min. The hot water extract was filtered through No. 2 filter
paper followed by a Millex GV membrane and freeze-dried,
and the lyophilizate (1 g) was then suspended in 2 ml of water
and subjected to reversed-phase flash column chromatogra-
phy using an Isolera Spektra (Biotage, Sweden, Uppsala).
Antiviral activity of each fraction was determined with antivi-
ral assay described earlier. The active fractions were analyzed
by liquid chromatography quadrupole time-of-flight mass
spectrometry (LC/qTOF-MS).
Analysis of the fractions containing antiviral activity was
performed according to the method described by Kammerer
et al. [18] with some modifications.
Statistical Analyses
Viral titers in the time-of-addition assay and antiviral assay for
the soybean fractions were analyzed by Student’s t test using
Excel Toukei ver. 6.0 (Esumi, Tokyo, Japan). Values are pre-
sented as mean ± standard deviation (SD). P < 0.05 was con-
sidered statistically significant.
Results and Discussion
All four components of the adlay tea inhibited virus multipli-
cation of all the laboratory-adapted and clinical isolates of
influenza A and B viruses (Table 1), and effectiveness against
oseltamivir resistant viruses such as Osaka/2024/2009 and
Osaka/71/2011, implying that the mechanism of action of
these components might differ from that of the inhibitor.
Adlay seeds and soybeans were especially effective against
type B viruses, suggesting a relationship between the antiviral
activity of the components and the antigenic structure of the
IFV. Soybeans contain many isoflavones [19], which have
anti-IFVactivity [20]. In the present study, soybeans exhibited
the strongest activity. This was probably related to isoflavones
contained. However, in our previous study, antiviral activity of
adlay tea did not correlate with the polyphenol content [15],
suggesting that adlay tea has many active ingredients other
than polyphenols, and that polyphenols are not the principal
active ingredients.
To investigate the stage of virus infection inhibited by the
four components, we performed a time-of-addition assay in
which the infection periods followed five patterns (Fig. S1):
pretreatment before virus adsorption (Pattern 1), virus adsorp-
tion (Pattern 2), virus replication (Pattern 3), virus replication
at an early stage (Pattern 4), and virus replication at a late stage
(Pattern 5). The results are shown in Fig. 1. All the compo-
nents blocked virus adsorption most strongly in the infection
periods and the inhibition rate is more than 90%. Virus repli-
cation was also inhibited by all the components, although the
naked barley seeds and cassia seeds were ineffective at the late
stage of virus replication.
Because the components inhibited both virus adsorption
and replication in the time-of-addition assay, we examined
the mechanism of action in more detail by performing hem-
agglutination inhibition and cell fusion inhibition assays.
However, viral neutralization and inhibition of cell fusion
were not confirmed with any of the components (data not
shown). During the growth process of the IFV, hemagglutinin
binds to sialic acid on host cells and is taken up into the cells.
Synthesis of the uncoated viral RNA (vRNA) and protein then
occurs. The synthesized HA, NA, M1 and M2 protein are
incorporated into the cell membrane of the host. New viral
RNPs (vRNPs) composed of vRNA and viral protein PB1,
PB2, PA and NP are transported to cell surface. Finally, the
vRNPs acquire the cell membrane incorporating HA, NA,M1
and M2, and are released extracellular as a virion [21]. In the
time-of-addition assay, all the components showed inhibitory
effects during pretreatment, adsorption, and replication, indi-
cating the possibility that binding between hemagglutinin and
sialic acid is blocked, or of viricidal effects. However, none of
the components showed any inhibitory effect in the hemag-
glutination inhibition assay. The fact strongly suggests that
these components acted via other mechanism, such as inhibi-
tion similar to that by endocytosis inhibitors. In addition, the
components showed no activity in the cell fusion inhibition
assay, indicating that antiviral activity of the components was
unrelated to hemagglutinin.
In this study, all four components showed inhibitory effects
during pretreatment before adsorption of the virus, i.e., the
components might affect cell function, such as a signaling
pathway. Indeed, a relationship between the IFV replication
process and the signaling pathway such as P13K/AKT and
Raf/Mek/ERK has been reported [22, 23]. These results sug-
gest that the components of adlay tea exert a novel mechanism
of action against the IFV, and that each component contains
several active ingredients and exhibits antiviral activity at var-
ious stages.
Antiviral activity of the hot water extract of soybeans
against PR/8/34 was measured for each collected fraction
(Fig. S2). Fractions 1 and 2 and fractions 12–23 showed anti-
viral activity. The adsorbed active fractions (fractions 12–23)
were analyzed by LC/qTOF-MS, with the mass detection
using the target ions [M +H]+ or [M −H]−. With fractions
16 and 17, the ion peak was detected at m/z 253.0516 in the
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negative ion mode; this was thought to be daidzein, which has
a molecular weight (MW) of 254. Considering fractions 18–
20, the ion peak was detected at m/z 285.0765 in the positive
ion mode for glycitein or biochanin A, as both have anMWof
284. The result obtained by SIM measurement of LC/MS for
the retention time revealed that the peak of 18–20 fractions
using LC/MS was completely overlapped by glycitein and not
by biochanin A. With fractions 19–22, the ion peak was de-
tected at m/z 271.0606 in the positive ion mode by using
genistein, with an MWof 270. Here, we checked the antiviral
activity of these components against PR/8/34 using the stan-
dard substances, which were isolated from soybean. As a re-
sult, it is suggested that daidzein and glycitein, as presented in
Table 2, are involved as active ingredients in fraction 16–20 of
the chromatography. Glycitein has not previously been report-
ed to exhibit anti-IFV activity; this was a novel finding of the
present study. However, other fractions also showed antiviral
activity, suggesting that there are many active ingredients oth-
er than daidzein and glycitein. Thus, antiviral effect of soy-
beans is probably the combined effect of several ingredients.
Further study is needed to identify other active ingredients and
establish the mechanism of action.
Fig. 1 The inhibition stages of the four components of adlay tea in virus multiplication. aAdlay seeds (Akishizuku); b soybeans (Sachiyutaka); c naked
barley seeds (Ichibanboshi); and d cassia seeds. *P < 0.05; **P < 0.01; ***P < 0.001
Table 2 Antiviral activity of daidzein and glycitein
Compound IC50 (μM or nM)
a SIb
Daidzein 143.6 ± 78.9 >27
Glycitein 204.7 ± 21.0 >17,182
a The values are averages of results in antiviral assay against A/PR/8/34,
from two independent experiments
The IC50 of daidzein and glycitein are given in μM and nM, respectively
b Selectivity index = CC50/IC50 (IC50, half maximal inhibitory concentra-
tion; CC50, 50% cytotoxicity concentration)
Plant Foods Hum Nutr (2019) 74:538–543542
Author's personal copy
Conclusions
This study showed antiviral activity by the four components
of adlay tea (adlay seeds, naked barley seeds, soybeans, and
cassia seeds). In the four components, soybean showed the
strongest activity. When trying to purify the active ingredient
from soybean, daidzein and glycitein were identified. Anti-
IFV action of glycitein was the first report.
The intake of these components may be effective in pre-
vention and treatment of influenza, as these components
inhibited the virus adsorption and replication in this study. In
order to clarify the effectiveness as a functional food, we need
to conduct animal experiments and to check their effect on
human population through a questionnaire in future studies.
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